How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care

BACKGROUND: Thrombolysis using intravenous (IV) tissue plasminogen activator (tPA) is one of few evidence-based acute stroke treatments, yet achieving high rates of IV tPA delivery has been problematic. The 4.5-h treatment window, the complexity of determining eligibility criteria and the availabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Christine L., Ryan, Annika, Rose, Shiho, Attia, John R., Kerr, Erin, Koller, Claudia, Levi, Christopher R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825073/
https://www.ncbi.nlm.nih.gov/pubmed/27059183
http://dx.doi.org/10.1186/s13012-016-0414-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825073/
https://www.ncbi.nlm.nih.gov/pubmed/27059183
http://dx.doi.org/10.1186/s13012-016-0414-6

Ejemplares similares